Skip to search formSkip to main contentSkip to account menu

In Stent Restenosis

Fifty percent or greater stenosis within an existing stent. (ACC)
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2019
2019
Impact of Plaque Calcification and Stent Oversizing on Clinical Outcomes of Atherosclerotic Femoropopliteal Arterial Occlusive Disease Following Stent Angioplasty.
Review
2018
Review
2018
Treatment of Femoropopliteal Artery In-stent Restenosis
Femoropopliteal (FP) artery-in stent restenosis (ISR) is a daunting management problem that we continue to face. FP artery-ISR… 
2015
2015
Higher plasma level of STIM1, OPG are correlated with stent restenosis after PCI.
OBJECT Percutaneous Coronary Intervention (PCI) is one of the most effective treatments for Coronary Heart Disease (CHD), but the… 
Review
2015
Review
2015
Association of smoking with restenosis and major adverse cardiac events after coronary stenting: A meta-analysis
Background and Objective: The association between smoking and clinical outcomes after coronary stenting is controversial. The aim… 
2012
2012
A role for MRP8 in in stent restenosis in diabetes.
Review
2011
Review
2011
Drug eluting versus bare metal stents in cardiac allograft vasculopathy
Background: Cardiac allograft vasculopathy (CAV) is a distinct pathological condition characterized by diffuse and progressive… 
2009
2009
Interleukin 8 gene polymorphisms and susceptibility to restenosis after percutaneous coronary intervention
Interleukin-8 is a strong mediator of inflammation and has been implicated in the biochemical pathways involved in a wide range… 
2007
2007
Stent material surface and glucose activate mononuclear cells of control, type 1 and type 2 diabetes subjects.
In stent restenosis (ISR) has been described as an unaccomplished tissue healing and its rate is particularly high in diabetic… 
2005
2005
Rapamycin inhibits human in stent restenosis vascular smooth muscle cells independently of pRB phosphorylation and p53.
2005
2005
Drug‐eluting stents for the treatment of in‐stent restenosis – ‘real world’ double centre experience in consecutive patients
OBJECTIVES. We evaluated clinical outcome of consecutive patients with in stent restenosis (ISR) treated with drug‐eluting stents… 
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)